The mTOR inhibitor, rapamycin, has been shown to be effective to rescue some phenotypes caused by these mutations and has been used as a therapeutic agent to treat some of the autism symptoms (Meikle et al., 2008; Ehninger and Silva, 2011; Curatolo et al., 2016). This evidence concerns the gene MTOR and autism.